News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, April 12, 2021

ORA Research News - Monday, April 12, 2021

NIH REMINDER: Required Use of Two-Factor Authentication Using Login.Gov for eRA's External Modules in 2021 (NOT-OD-21-040)  https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-040.html

 

ORA Noon Conference offered via Zoom

SAVE THE DATE!  April 21, 2021 at 1:00 pm

Topic: Writing NIH Other Support Pages

Required Changes as of May 25, 2021

 

Pew-Stewart Scholar Program for Cancer Research

The Pew-Stewart Scholars Program for Cancer Research supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. The program is in line with the Stewart Trust's mission to invest in innovative, cutting-edge, basic cancer research that may accelerate and advance progress toward a cure for cancer; one application can be submitted from the Stephenson Cancer Center.  Pre-proposals are being requested from interested early-stage faculty performing cancer research.

Award Amount: $300,000 in flexible support—$75,000 per year

Award Period: Four-years

Pre-Proposal Deadline: May 3, 2021

Please see attachment for information on Eligibility and Pre-Proposal Application Details.

Should you have any questions, please contact CancerResearch@ouhsc.edu.

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu).  

  1. Johnson & Johnson is seeking to engage with academic partners to:
  • Improve the precision of immunotherapies through cell targeting – focusing on rheumatology, dermatology, GI inflammation and other inflammatory diseases.
  • Detect gut barrier dysfunction – focusing on chronic inflammatory diseases.
  • Promote resolution of inflammation by driving pro-resolution responses in innate immune cells focusing on autoimmune and/or chronic inflammatory diseases.

Submission entails a 1-pg non-confidential summary of technology (deadline 4/23/2021)

  1. A company (requested anonymity) is seeking to engage with academic partners to:
    • Develop lymphatic-based disease solutions – focusing on minimally invasive treatments

Submission entails a 1-pg non-confidential summary of technology (deadline 5/7/2021)

  1. Pfizer’s Centers for Therapeutic Innovation (https://www.pfizercti.com) is seeking collaborative proposals for developing novel therapeutic targets with application in:
  • Oncology: tumor targeted, immuno-oncology, cancer vaccines
  • Internal medicine: obesity/cachexia, heart failure, diabetic/CKD, NASH/T2D
  • Inflammation and immunology: rheumatology, gastroenterology, medical derm
  • Rare disease: cardiology, neuro-musc., metabolic, hematology

Preference is for novel biological targets supported by in vivo and in vitro models, enabling genetics and mechanistic insights, translational biochemical or cellular assay and biomarkers.  Out of scope: drug repurposing, standalone biomarker assays/platforms, medical devices, cell-based therapies. 

Proposal template available upon request (submission deadline 6/18/21).

 

OUHSC HSC COVID-19 Return Plan - now the HSC COVID-19 Response Plan - effective February 16, 2021. 

This revised Plan (https://www.ouhsc.edu/coronavirus) includes some minor clarifications to current HSC COVID-19 protocols, as well as some more substantive revisions, including:

Adoption and implementation of updated testing and quarantine/isolation protocols following employee and student return from international travel and from cruises, based on recent federal executive order requirements (Sections VIII, IX).  Please note that under the new protocols, individuals returning from international travel or from domestic or international cruises will typically have to quarantine/isolate from campus for 7 calendar days and receive a negative test prior to return. Individuals traveling internationally or taking cruises must be prepared to take leave (paid or unpaid, as appropriate) during the quarantine/isolation period communicated by Student/Employee Health, particularly if their position or responsibilities are not approved for or appropriate for remote work. Students must be prepared to be away from academic and clinical responsibilities during the designated quarantine/ isolation period.

Requirement that even those fully vaccinated must complete the online COVID-19 Screening and Reporting Tool (Sections VII, IX).   At this time, the CDC has issued limited guidance on how completion of the COVID-19 vaccine series will impact exposure assessment.  We will continue to monitor and will make adjustments to this requirement as needed. The Travel FAQs and the instructions for when to complete the online COVID-19 Screening and Reporting Tool, have been updated. The Tool itself has already been updated to reflect the changes above.

 

PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS

The Presbyterian Health Foundation (PHF) will fund $4.15M in grants for 2021.  Information on the PHF Grant Programs for Spring 2021 and Guidelines and Application for each of the grant programs listed below may be found at https://research.ouhsc.edu/Resources/PHF-Funding-2021.  All guidelines have been recently updated to reflect that funds may not be requested for student tuition and fees. If you have any questions, please email ORA4PHF@ouhsc.edu.

Grant Type

Deadline

Bridge

April 30, 2021

 

REMINDER ON COVID-19 MITIGATION STRATEGIES IN THE RESEARCH ENVIRONMENT

With the current increase in COVID-19 cases across Oklahoma, this is a good time to do the following:

  • Encourage everyone on your team to telecommute as much as possible; reducing the number of individuals in buildings and the research environment will help in reducing potential transmission of the virus.
  • Follow your approved COVID-19 Standard Operating Procedures for your laboratory; be certain these are current and are posted on the lab door and inside the laboratory.
  • Familiarize yourself with OU Health Sciences Center COVID-19 Resources 
  • https://www.ouhsc.edu/coronavirus).
  • Follow all masking and social distancing guidelines as described in the OUHSC COVID-19 Return Plan
  • https://www.ouhsc.edu/coronavirus); wash your hands often.
  • It’s a good practice to follow the HSC’s COVID-19 protocols even when you are home or in the community – masking, social distancing, and good hand hygiene help protect you, your colleagues, and your loved ones.

 

Oklahoma Covid-19 Working Group

Information on research activities in Oklahoma that address the Covid-19 pandemic has been added to the  OCTSI Website (http://octsi.ouhsc.edu/covid-19%20working%20group) A list of investigators in the working group and their planned or ongoing projects are described. A list of funded Covid-19 Seed Projects at OUHSC and OU Norman is also included. To be added to the Oklahoma Covid-19  Working Group or to have your information updated, please contact: Mark L. Lang PhD, Presbyterian Health Foundation Presidential Professor, Department of Microbiology and Immunology, OUHSC ( mark-lang@ouhsc.edu ).

Up to date information on allowable OUHSC research activity in response to COVID-19 can be found at:  

https://research.ouhsc.edu/Resources/COVID-Research-Updates

 

NIH NOTICES

Reminders of NIH Policies Related to Closeout (NOT-OD-21-102)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-102.html

Notice of NIGMS Funding Priorities for PAR-19-301 "Limited Competition: NIGMS National and Regional Resources (R24 Clinical Trial Not Allowed)" (NOT-GM-21-036)

https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-036.html

Updated Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19 (NOT-HL-21-009)

https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-009.html

Notice of Correction to Key Dates of NOT-MH-21-105, Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure (NOT-MH-21-255)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-255.html

Notice of Correction to NOT-OD-21-071 Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focuses on Maternal Health, Structural Racism and Discrimination, and COVID-19 (NOT-OD-21-090)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-090.html

Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council (NOT-OD-21-095)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-095.html

Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional) (NOT-OD-21-097)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-097.html

Registration is Now Open for the 2021 HHS Small Business Program Conference on April 26-30! (NOT-OD-21-098)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-098.html

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2021 SGM Research Investigator Awards Program (NOT-OD-21-099)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-099.html

Notice of Change: Extension of PA-18-926, Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional) (NOT-AI-21-042)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-042.html

Notice of Expansion of Research Scope of RFA-AI-21-004 "Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed) (NOT-AI-21-044)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-044.html

Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-21-109 Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) (NOT-AI-21-047)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-047.html

Notice of Clarification of Eligibility Regarding Foreign Components for PAR-19-257, "Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)" (NOT-AR-21-021)

https://grants.nih.gov/grants/guide/notice-files/NOT-AR-21-021.html

Notice of Change to Key Dates for NIDA PAR-21-183, " Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)" (NOT-DA-21-042)

https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-042.html

Notice of Change to Key Dates for NIDA PAR-21-208, " Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)" (NOT-DA-21-043)

https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-043.html

Notice of Change to Funding Opportunities for NOT-EB-20-017, "Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications" (NOT-HD-21-017)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-017.html

Notice of Change in Advisory Council Review for RFA-MD-21-006 "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)" (NOT-MD-21-017)

https://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-017.html

Notice of Participation of NIMH in NOT-EY-21-001, "Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities" (NOT-MH-21-245)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-245.html

Notice of Extension to PAR-18-894, "Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)" (NOT-MH-21-250)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-250.html

Notice of Change to Expiration Date for OBSSR RFA-OD-21-005 "Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed) (NOT-OD-21-096)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-096.html

Notice of Intent to Publish a Funding Opportunity Announcement for Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) (NOT-CA-21-045)

https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-045.html

Notice of Intent to Publish a Funding Opportunity Announcement for The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) (NOT-CA-21-050)

https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-050.html

Notice of Intent to Publish a Funding Opportunity Announcement: Early Detection Research Network (EDRN) Clinical Validation Centers (NOT-CA-21-051)

https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-051.html

Notice of Intent to Publish a Funding Opportunity Announcement: Early Detection Research Network (EDRN) Data Management and Coordinating Center (NOT-CA-21-052)

https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-052.html

Notice of Intent to Publish a Funding Opportunity Announcement for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional) (NOT-HG-21-024)

https://grants.nih.gov/grants/guide/notice-files/NOT-HG-21-024.html

Notice of Intent to Publish a Funding Opportunity Announcement for Joint NINDS and NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) (NOT-NS-21-050)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-050.html

Notice of Intent to Publish the Reissuance of RFA-NS-18-020, BRAIN Initiative: Novel Technologies and Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (NOT-NS-21-051)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-051.html

Notice of Intent to Publish the Reissuance of RFA-NS-18-019, BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) (NOT-NS-21-052)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-052.html

Notice of Intent to Publish the Reissuance of PAR-18-422, NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) (NOT-NS-21-055)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-055.html

2021 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Now Available (NOT-AI-21-045)

https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-045.html

Notice of Special Interest (NOSI): Deciphering the Mosaic of Glia in the Addicted Brain (NOT-DA-21-001)

https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-001.html

Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity (NOT-DA-21-014)

https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-014.html

Notice of Special Interest: Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21) (NOT-HD-21-024)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-024.html

Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children (NOT-MH-21-225)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-225.html

Notice of Special Interest (NOSI) for Illuminating the Druggable Genome (IDG) Initiative: Request for Administrative Supplements to Existing Grants for Incorporating Single Cell Data into the IDG Knowledgebase (NOT-RM-21-019)

https://grants.nih.gov/grants/guide/notice-files/NOT-RM-21-019.html

Please Note:  When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

NIH DEADLINES

Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) (PA-21-199)
Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-199.html

Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) (PA-21-200)
Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-200.html

Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) (PA-21-201)
Deadline June 5, 2021 and October 5, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-201.html

Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials) (PA-21-214)

Deadline June 12, 2021 and February 12, 2022

https://grants.nih.gov/grants/guide/pa-files/PA-21-214.html

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System

(U44 Clinical Trial Optional) (PAR-21-162) - Deadline August 10, 2021 and February 9, 2022

https://grants.nih.gov/grants/guide/pa-files/PAR-21-162.html

Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) (PAR-21-185)

Deadline May 28, 2021 and September 24, 2021 

https://grants.nih.gov/grants/guide/pa-files/PAR-21-185.html

NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) (PAR-21-187)

Deadline May 28, 2021 and September 24, 2021 

https://grants.nih.gov/grants/guide/pa-files/PAR-21-187.html

Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
(PAR-21-196) - Deadline October 14, 2021 and October 14, 2022

https://grants.nih.gov/grants/guide/pa-files/PAR-21-196.html

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement

(UG3/UH3 Clinical Trial Required) (PAR-21-197) - Deadline June 8, 2021 and October 6, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-197.html

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

(PAR-21-210) - Deadline June 5, 2021 and October 5, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-210.html

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)

(PAR-21-211) - Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html

Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) (RFA-AI-21-009)

Deadline July 30, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-009.html

Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) (RFA-AI-21-012)

Deadline August 4, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-012.html

Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed) (RFA-AI-21-019)
Deadline August 24, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-019.html

 

Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)
(RFA-AI-21-023) - Deadline July 30, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-023.html

Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)
(RFA-AI-21-024) – Deadline August 4, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-024.html

Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) (RFA-AI-21-025)
Deadline July 30, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-025.html

Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus,

Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) (RFA-AR-21-015) - Deadline July 15, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-21-015.html

Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and

Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) (RFA-AR-21-016) – Deadline July 15, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-21-016.html

Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)

(RFA-DA-22-002) - Deadline August 9, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-002.html

Nutrition Obesity Research Centers (P30 Clinical Trial Optional) (RFA-DK-21-015)
Deadline October 20, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-015.html

Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional) (RFA-HD-22-010)

Deadline July 29, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-010.html

User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed) (RFA-HD-22-019)

Deadline July 29, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-019.html

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)

(RFA-HG-21-006) - Deadline June 25, 2021 and March 1, 2022

https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-006.html

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed)

RFA-HG-21-007) – Deadline June 25, 2021 and March 1, 2022 

https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-007.html

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
(RFA-HG-21-008) - Deadline June 25, 2021 and March 1, 2022 

https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-008.html

Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not

Allowed) (RFA-RM-21-012) - Deadline July 15, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-012.html

Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial

Not Allowed) (RFA-TR-21-015) - Deadline June 28, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-21-015.html

OTHER FEDERAL DEADLINES

Department of Defense (DOD) – Peer Reviewed Alzheimer’s Research Program (PRARP) – Convergence Science Research Award

Required Preapplication due June 14, 2021

https://cdmrp.army.mil/funding/prarp

DOD – PRARP – Innovation in Care and Support Award – Required Preapplication due June 14, 2021

https://cdmrp.army.mil/funding/prarp

DOD – PRARP – Research Partnership Award – Required Preapplication due June 14, 2021

https://cdmrp.army.mil/funding/prarp

DOD – PRARP – Accelerating Diagnostic Research Award – Required Preapplication due June 14, 2021

https://cdmrp.army.mil/funding/prarp

DOD – PRARP – Leveraging Approaches for Innovation in Care and Support Award – Required Preapplication due June 14, 2021

https://cdmrp.army.mil/funding/prarp

DOD – Peer Reviewed Orthopaedic Research Program (PRORP) – Applied Research Award (ARA)

Required PreApplication due May 27, 2021

https://cdmrp.army.mil/funding/prorp

DOD – PRORP – Clinical Trial Award (CTA) – Required PreApplication due May 27, 2021

https://cdmrp.army.mil/funding/prorp

DOD – PROP – Clinical Translational Research Award (CTRA) – Required Preapplication due May 27, 2021

https://cdmrp.army.mil/funding/prorp

Environmental Protection Agency (EPA) – Postdoctoral Fellowship in Laboratory Systems Data Analysis

Deadline April 29, 2021 3:00:00 PM Eastern Time Zone

https://www.zintellect.com/Opportunity/Details/EPA-OTAQ-2021-03

EPA – Postdoctoral Fellowship in Bioinformatics and Computational Toxicology – Deadline May 24, 2021

3:00:00 PM Eastern Time Zone

https://www.zintellect.com/Opportunity/Details/EPA-ORD-CCTE-GLTED-2021-01

EPA – Postdoctoral Fellowship in Chemical Impacts of PFAS Chemicals on the Thyroid System

Deadline June 1, 2021 3:00:00 PM Eastern Time Zone

https://www.zintellect.com/Opportunity/Details/EPA-ORD-CCTE-GLTED-2021-02

EPA – Postdoctoral Fellowship in Thyroid Translational Toxicology – Deadline June 1, 2021 3:00:00 PM Eastern Time Zone

https://www.zintellect.com/Opportunity/Details/EPA-ORD-CCTE-GLTED-2021-03

OTHER DEADLINES

Alzheimer’s Drug Discovery Foundation – Harrington Scholar Award – Letter of Intent Deadline April 23, 2021

https://mailchi.mp/alzdiscovery/april-23-deadline-approaching-for-2021-addf-harrington-scholar-award?e=8730f4571b

American Diabetes Association (ADA) – Postdoctoral Fellowship – Deadline May 3, 2021

https://professional.diabetes.org/content/targeted-rfas

ADA – Innovative Clinical or Translational Science – Required Letter of Intent Deadline April 26, 2021

https://professional.diabetes.org/content/targeted-rfas

ADA – Junior  Faculty – Required Letter of Intent Deadline April 26, 2021

https://professional.diabetes.org/content/targeted-rfas

American Cancer Society (ACS) – Research Scholar Grant – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Clinician Scientist Development Grant – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Postdoctoral Fellowship – Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

ACS – Clinical Research Professor Award – Letter of Intent Deadline October 15, 2021

https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

Print